GlobeNewswire Inc.··Ac Immune SaAC Immune, Lilly Expand Tau Partnership With $11M Upfront as Alzheimer's Race Heats Up
AC Immune and Eli Lilly amend collaboration to advance tau-targeting Alzheimer's candidates, with $11M upfront and IND studies starting mid-2026.
LLYACIUneurodegenerative diseasesAlzheimer's disease